Strategic Information for the Life Science and Analytical Instrument Industry
Overview One of the latest major developments in the quest for greater use of new approach methodologies (NAMs), which are broadly defined as alternatives to animal testing for studying environmental and human health hazards, is the EU’s publication of its “Roadmap Towards Phasing Out Animal Testing for Chemical Safety Assessments.” Adopted by the European Commission […]
MOBILion Systems set out in 2015 to disrupt the LC-MS market. The company’s Structures for Lossless Ion Manipulation (SLIM)technology utilizes a printed circuit board and electrical fields to move ions along what the company describes as a “serpentine path,” replacing the shorter straight ion flight path found in other high-resolution IMS systems. Because the ions […]
At the Society for Lab Automation and Screening (SLAS) 2026, Carterra introduced its latest surface plasmon resonance (SPR) system, the Carterra Vega High-Throughput Surface Plasmon Resonance (HT-SPR) instrument. The system will expand the company’s presence into primary screening, one of the first stages of drug discovery, in addition to secondary screening, where SPR has traditionally […]
According to a report from the National Science Foundation published this month, in FY24 (ending September 30, 2024), overall R&D spending (science and engineering and non-science and engineering) by US higher education institutions grew 8.1% to $117,719 million. The federal government was the leading source of spending. But spending growth was the fastest for state […]
On February 7, 2025, the Trump administration announced a 15% cap on all indirect costs for new and existing NIH grants. However, on April 4, 2025, the US District Court in Massachusetts enacted a preliminary injunction blocking the limit. In response, the HHS appealed the injunction to the US Court of Appeals for the First […]
A new report from Strategic Directions International (SDi), a business intelligence firm specializing in the analytical instrument market, finds that the compound annual growth rate (CAGR) between 2024 and 2029 of demand in the cell and gene therapy (C>) market for seven categories of analytical technologies will expand in the high single digits. The technologies […]
10x Genomics has begun shipping its latest Flex assay for its Chromium instrument platform, responding to the needs of the single-cell sequencing market for easy to use, higher-throughput and scalable solutions. For example, the burgeoning field of cell atlases, or maps of an organism’s cells, requiring larger data sets and thus the faster generation of […]
Share repurchase programs have been a heavily discussed topic among investors and analysts, with some questioning their relationship to a company’s financial health. Among the leading reasons companies initiate share repurchase programs is to reduce the number of outstanding shares, thereby increasing the value of the remaining shares. Additionally, companies buy back shares to demonstrate […]
As the life science analytical instrument industry faces the challenges presented by uncertain government and academic funding and slower CapEx spending by biopharma companies, plus nervousness from potential investors, companies introducing new technology for life science research are facing a more difficult environment for raising money. Formed earlier this year, Precision Cell Systems (PCS) is […]
The first analytica USA exhibition and conference will be held in Columbia, Ohio, from September 10 to 12. This is the first time analytica, a series of lab technology, analysis and biotech exhibitions held worldwide by trade fair organization Messe München, will take place in the US. analytica USA will host 260 plus exhibitors. analytica […]
